Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hinkle

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Journal of Academic Ophthalmology (2017)|June 30, 2023
Virtual Ophthalmology Fellowship Interviews: Perceptions of U.S. Ophthalmology Fellowship Applicants in 2020Samir N Patel, Elliot G Cherkas, Charlotte N Shields, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2009
Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitorsAlex G Waterson, Kimberly G Petrov, Keith R Hornberger, et al.
British Journal of Cancer|August 26, 2004
Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour modelsI K Dev, R E Dornsife, T M Hopper, et al.
American Journal of Ophthalmology|December 14, 2020
Comparison Between Graders in Detection of Diabetic Neovascularization With Swept Source Optical Coherence Tomography Angiography and Fluorescein AngiographyHasenin Al-Khersan, Jonathan F Russell, Thomas A Lazzarini, et al.
Journal of Medicinal Chemistry|July 16, 2008
Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitorPhilip A Harris, Amogh Boloor, Mui Cheung, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Journal of Academic Ophthalmology (2017)|June 30, 2023
Virtual Ophthalmology Fellowship Interviews: Perceptions of U.S. Ophthalmology Fellowship Applicants in 2020Samir N Patel, Elliot G Cherkas, Charlotte N Shields, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2009
Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitorsAlex G Waterson, Kimberly G Petrov, Keith R Hornberger, et al.
British Journal of Cancer|August 26, 2004
Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour modelsI K Dev, R E Dornsife, T M Hopper, et al.
American Journal of Ophthalmology|December 14, 2020
Comparison Between Graders in Detection of Diabetic Neovascularization With Swept Source Optical Coherence Tomography Angiography and Fluorescein AngiographyHasenin Al-Khersan, Jonathan F Russell, Thomas A Lazzarini, et al.
Journal of Medicinal Chemistry|July 16, 2008
Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitorPhilip A Harris, Amogh Boloor, Mui Cheung, et al.
Pageof 4